Adeno-associated virus analysis by size exclusion chromatography within 3 minutes using short bio-inert columns made with 3 µm particles operated at high flowrates
Authors:
- 26 January 2024
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1718, 464684
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Multiple-Monitor HPLC Assays for Rapid Process Development, In-Process Monitoring, and Validation of AAV Production and PurificationPharmaceutics, 2021
- Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene TherapyBiotechnology Journal, 2020
- Production, Processing, and Characterization of Synthetic AAV Gene Therapy VectorsBiotechnology Journal, 2020
- Adeno-associated virus vector as a platform for gene therapy deliveryNature Reviews Drug Discovery, 2019
- Pharmaceutical Development of AAV-Based Gene Therapy Products for the EyePharmaceutical Research, 2018
- Gene therapy comes of ageScience, 2018
- Viral Vectors for Gene Therapy: Translational and Clinical OutlookAnnual Review of Biomedical Engineering, 2015
- Analytical Ultracentrifugation as an Approach to Characterize Recombinant Adeno-Associated Viral VectorsHuman Gene Therapy Methods, 2015
- Theory and practice of size exclusion chromatography for the analysis of protein aggregatesJournal of Pharmaceutical and Biomedical Analysis, 2014
- Manufacturing and characterizing AAV-based vectors for use in clinical studiesGene Therapy, 2008